Categories: News

Seven Bridges Expands Platform to Support Execution of Nextflow and WDL Workflows

BOSTON, March 10, 2022 /PRNewswire/ — Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced the expansion of its platform to enable execution of workflows written in Nextflow and Workflow Description Language (WDL). In addition, the Seven Bridges platform will continue to support Common Workflow Language (CWL). This expansion will now empower more scientists to use the Seven Bridges interface in a secure, compliant, collaborative environment, to run tools described in the workflow language of their choice.

CWL, WDL and Nextflow offer unique characteristics that make them attractive to researchers…

“CWL, WDL and Nextflow offer unique characteristics that make them attractive to researchers with varied expertise and at different phases of the research lifecycle,” said Jeff Gentry co-founder of WDL and CWL leadership member. “By supporting multiple workflow languages, Seven Bridges makes it easier for researchers to realize the benefit of reproducible analysis at scale.” 

In addition to the more than 600 optimized CWL workflows available from Seven Bridges, this release enables researchers to leverage large content repositories of WDL and Nextflow workflows, in addition to workflows developed in-house, on the Seven Bridges platform.

Seven Bridges is the leading provider of interoperable data ecosystems and this release underscores the company’s commitment to adopting standards that improve and accelerate researcher’s ability to extract meaningful insights from large, multi-dimensional data.

“The development and adoption of standards for secure data exchange and portable, reproducible analysis is critical to realizing the promise of precision medicine, particularly when data are housed in geographically diverse regions or with varied access requirements,” said Brandi Davis-Dusenbery, Chief Scientific Officer at Seven Bridges. “This expansion, when coupled with our industry leading multi-cloud capabilities, enables more researchers across the world to effectively generate insights from large biomedical datasets.”

About Seven Bridges
Seven Bridges enables researchers to extract meaningful insights from genomic and phenotypic data in order to advance precision medicine. The Seven Bridges Ecosystem consists of a compliant analytic platform, intelligently curated content, transformative algorithms, unprecedented access to federated data sets, and expert on-demand professional services. This holistic approach to bioinformatics is enabling researchers — at the world’s leading academic, biotechnology, clinical diagnostic, government, medical centers, and pharmaceutical entities — to increase R&D efficiency, enhance the hypothesis resolution process, isolate critical biomarkers, and even turn a failing clinical trial around while also reducing computational workflow times and data storage costs. To learn more, visit sevenbridges.com or follow us on LinkedIn and Twitter.

Media Contact
Valerie Enes
valerie@teamseismic.com
408-497-8568

View original content to download multimedia:https://www.prnewswire.com/news-releases/seven-bridges-expands-platform-to-support–execution-of-nextflow-and-wdl-workflows-301499750.html

SOURCE Seven Bridges

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

2 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

5 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

5 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

5 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

5 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

5 hours ago